Atenolol treatment for severe Infantile Hemangiomas: a single-centre prospective study

Abstract

Infantile hemangiomas (IHs) are common benign vascular tumors of infancy with an incidence of 4-5% ¹. The majority of IHs are self-limited, though in approximately 10% of patients, when their lesions compromise vital and sensory functions or cause disfigurement, medical treatment is warranted ^2,3. Τhe most exciting development in the treatment for IHs over the last decade has been the discovery of propranolol's effects during the proliferative phase of the hemangioma cycle ⁴.

This article is protected by copyright. All rights reserved.

http://ift.tt/2x8oRKR